Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strategy to resolve left ventricular outflow tract obstruction (LVOTO) in patients with hypertrophic cardiomy-opathy who remain symptomatic on maximally tolerated medical therapy. Firstly performed by Sig-wart in 1994, the procedure consists in determining an iatrogenic infarction of basal interventricular septum to reduce LVOTO and alleviate symptoms. Since its first description, numerous studies demonstrated its efficacy and safety, proposing ASA as a valid and attractive alternative to surgical septal myectomy. The success rate of the intervention is profoundly impacted by patient selection and center experience. In this review we sought to summarize current evidence on ASA, describing the procedure and proposing a cardiomyopathy team-based approach to resolve clinical disputes in clinical practice

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. a contemporary reappraisal / Pelliccia, Francesco; Niccoli, Giampaolo; Gragnano, Felice; Limongelli, Giuseppe; Moscarella, Elisabetta; Andò, Giuseppe; Ussia, Gian Paolo; Tarantini, Giuseppe; Esposito, Augusto; Stabile, Eugenio; Gimeno, Juan Ramon; Elliott, Perry; Calabrò, Paolo. - In: EUROINTERVENTION. - ISSN 1969-6213. - (2019). [10.4244/EIJ-D-18-00959]

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. a contemporary reappraisal

Pelliccia, Francesco
Investigation
;
2019

Abstract

Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strategy to resolve left ventricular outflow tract obstruction (LVOTO) in patients with hypertrophic cardiomy-opathy who remain symptomatic on maximally tolerated medical therapy. Firstly performed by Sig-wart in 1994, the procedure consists in determining an iatrogenic infarction of basal interventricular septum to reduce LVOTO and alleviate symptoms. Since its first description, numerous studies demonstrated its efficacy and safety, proposing ASA as a valid and attractive alternative to surgical septal myectomy. The success rate of the intervention is profoundly impacted by patient selection and center experience. In this review we sought to summarize current evidence on ASA, describing the procedure and proposing a cardiomyopathy team-based approach to resolve clinical disputes in clinical practice
2019
multidisciplinary heart team; hypertrophic cardiomyopathy; septal ablation
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. a contemporary reappraisal / Pelliccia, Francesco; Niccoli, Giampaolo; Gragnano, Felice; Limongelli, Giuseppe; Moscarella, Elisabetta; Andò, Giuseppe; Ussia, Gian Paolo; Tarantini, Giuseppe; Esposito, Augusto; Stabile, Eugenio; Gimeno, Juan Ramon; Elliott, Perry; Calabrò, Paolo. - In: EUROINTERVENTION. - ISSN 1969-6213. - (2019). [10.4244/EIJ-D-18-00959]
File allegati a questo prodotto
File Dimensione Formato  
Pelliccia_Alcohol_2019.pdf

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.16 MB
Formato Adobe PDF
2.16 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1287340
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 16
social impact